Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1Failure to adequately establish and maintain procedures for implementing corrective and preventive action, per 21 CFR 820.100(a).
Passage 2Failure to adequately develop, maintain, and implement written MDR procedures as required by 21 CFR 803.17. For example, during the inspection, your firm presented the following documents as your written MDR procedure.
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 803.17(a)(1)
- 21 CFR 803.3
- 21 CFR 803.50(a)
- 21 CFR 803.17(b)
- 21 CFR 803.18(b)(1)(i)
- 21 CFR 803.17
- 21 CFR 803
- 21 CFR 820.184
- 21 CFR 820.100(a)